about
Review article: the assessment and management of chronic severe gastrointestinal dysmotility in adultsEvaluation and management of dyspepsia.Innovative parenteral and enteral nutrition therapy for intestinal failure.Treatment options for functional gastrointestinal disorders: from empiric to complementary approaches.Management of functional abdominal pain and irritable bowel syndrome in children and adolescents.Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disordersMechano-transcription of COX-2 is a common response to lumen dilation of the rat gastrointestinal tract.Challenges and prospects for pharmacotherapy in functional gastrointestinal disorders.Functional abdominal pain and irritable bowel syndrome in children and adolescents.Needleless transcutaneous electroacupuncture improves rectal distension-induced impairment in intestinal motility and slow waves via vagal mechanisms in dogsMethionine enhances the contractile activity of human colon circular smooth muscle in vitroCellular mechanism of mechanotranscription in colonic smooth muscle cells.Pediatric intestinal failure: nutrition, pharmacologic, and surgical approaches.Irregular gastrointestinal drug absorption in Parkinson's disease.Development of drugs for gastrointestinal motor disorders: translating science to clinical need.Emerging drugs for functional dyspepsia.Acotiamide (Z-338, YM443), a new drug for the treatment of functional dyspepsia.Emerging drugs for functional dyspepsia.Current management of functional dyspepsia: impact of Rome III subdivision.
P2860
Q27030666-A06E61FF-583E-4A88-AC92-94CDE1C2FDF5Q30433839-076FAB54-628F-40FF-9BEE-36BDF9A85C6CQ33641177-CDF5D112-AA72-4F6D-8280-DE6A00EF3738Q33697091-9E84265E-AC60-4ECA-88DF-68752680D48BQ33995802-A26BE2E1-0B1C-456E-9EA2-6F852ED0874AQ34166903-CE0C66E5-3807-4145-8345-920A62777328Q34280328-13B41A31-5A5B-4A2C-AE1B-1C6A7324FD18Q34409219-F96944CD-19C9-47E0-A999-EE615C36C79FQ35079445-FFC7CFC8-38A6-4570-804D-ECEB515443F9Q35644257-F0DDDF02-02BC-4FF8-8807-C3E669F3B815Q36079056-3A689CAA-AC52-47CE-8887-14A9847BE8A0Q36309569-C82CAB18-866E-4794-907E-6574E176EEB4Q37016607-298AED2A-3FD1-47C8-B08D-ACF9B805CA83Q37076343-CEF41DEF-6A08-43A1-873A-17EAC32DCB73Q37079261-F4374FE0-BB3B-41CD-AEBA-19C1D028E676Q37854060-B64F4B57-F314-471A-989F-F619012AD214Q37854748-5D49BF08-0E2D-488E-8100-35CD0399A7F6Q38342083-2610BF5F-AE88-4449-BA56-DF6689862D61Q42406690-6C8FE15E-E3FE-403D-801B-32369322EEFB
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Promotility medications--now and in the future.
@ast
Promotility medications--now and in the future.
@en
Promotility medications--now and in the future.
@nl
type
label
Promotility medications--now and in the future.
@ast
Promotility medications--now and in the future.
@en
Promotility medications--now and in the future.
@nl
prefLabel
Promotility medications--now and in the future.
@ast
Promotility medications--now and in the future.
@en
Promotility medications--now and in the future.
@nl
P2860
P356
P1433
P1476
Promotility medications--now and in the future.
@en
P2093
P2860
P304
P356
10.1159/000092883
P577
2006-01-01T00:00:00Z